GENNIEFY
Market News
Latest financial news and analysis from global markets
AVGO
Meet the Super Semiconductor ETF With 40% of Its Portfolio Parked in Micron, AMD, Broadcom, Nvidia, and Intel
Artificial intelligence is driving blistering growth across the semiconductor industry.
INTC
Move Over, Magnificent 7, Now There's the AI 11
This episode breaks down what’s in the AI 11 basket, whether it's better to invest in baskets or individual companies, and the AI bubble.
HD
Home Depot tops first quarter earnings estimates on steady demand trends
Home Depot Inc (NYSE:HD, XETRA:HDI) reported first quarter fiscal 2026 results that topped Wall Street expectations for both earnings and revenue, while posting modest comparable sales growth. The home improvement retailer’s adjusted earnings per share (EPS) came in at $3.43, ahead of analyst...
XAU/USD
AngloGold Ashanti Cut to Underweight at ABSA: Has the Golden Run Finally Ended?
Shares of AngloGold Ashanti (NYSE:AU) just lost a key voice of support. ABSA Securities downgraded the gold miner to Underweight with a $100.82 price target, a notable bearish pivot after a powerful multi-year rally in both gold and gold mining equities. For long-term investors, the call raises a fair question: has the golden run finally ... AngloGold Ashanti Cut to Underweight at ABSA: Has the Golden Run Finally Ended?
NVDA
Nvidia and Apple hold stock market's power like never before: Chart of the Day
The S&P 500 has never been more concentrated in two stocks than it is today.
MSFT
Nvidia and Apple hold stock market's power like never before: Chart of the Day
The S&P 500 has never been more concentrated in two stocks than it is today.
AAPL
Nvidia and Apple hold stock market's power like never before: Chart of the Day
The S&P 500 has never been more concentrated in two stocks than it is today.
JNJ
Is BSX Stock A Value Trap Or A Rebound Play?
Boston Scientific (BSX) stock declined 47% over the last 12 months to trade near $57. Despite total revenues growing 17.4% to $20.6 billion and net income margins improving to 17.3%, the P/E multiple contracted by 70%. The selloff was triggered by a Q4 2025 GAAP EPS miss and a significant full-year 2026 organic growth guidance cut. The company's management lowered the target from a 10 to 11% range down to 6.5 to 8.0%, attributing the reset to greater-than-expected market share loss in the Electr
MDT
Is BSX Stock A Value Trap Or A Rebound Play?
Boston Scientific (BSX) stock declined 47% over the last 12 months to trade near $57. Despite total revenues growing 17.4% to $20.6 billion and net income margins improving to 17.3%, the P/E multiple contracted by 70%. The selloff was triggered by a Q4 2025 GAAP EPS miss and a significant full-year 2026 organic growth guidance cut. The company's management lowered the target from a 10 to 11% range down to 6.5 to 8.0%, attributing the reset to greater-than-expected market share loss in the Electr
INTC
1 Outstanding Growth Stock That Is a No-Brainer Buy on the Dip
It wouldn't be the first time in this stock's history that a sustained run follows a steep decline.
JNJ
3 Dividend Kings to Buy and Hold for 20 Years
When it comes to reliable dividend payouts, these three companies keep rewarding their long-term shareholders.
SHOP
1 Outstanding Growth Stock That Is a No-Brainer Buy on the Dip
It wouldn't be the first time in this stock's history that a sustained run follows a steep decline.